Two Dose-Equivalent, 56-Days, Subcutaneous (S.C.), Glucagon-Like Peptide 2 (Glp-2) Regimens, 1.6 Mg Once Daily (Od) Versus 0.4 Mg Four Times Daily (Qid), In The Treatment Of Short Bowel Syndrome (Sbs) Patients
Gastroenterology（2008）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要